SGHC Financial Statements & Analysis
Complete financial statements for SGHC including income statement, balance sheet, and cash flow statement. Analyze SGHC's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
31.4% ↑
Net Income
91.8% ↑
Gross Margin
-45.2% ↓
Operating Margin
22.8% ↑
Balance Sheet
Current Ratio
54.8% ↑
Debt to Equity
-20.1% ↑
Asset Turnover
13.7% ↑
Cash Flow
Operating Cash Flow
24.3% ↑
Net Cash Flow
-9.1% ↓
Free Cash Flow
63.3% ↑
Cash Flow to Debt
12.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.70B | 2.23B | 31.4% | |
| Gross Profit | 841.42M | 606.41M | 27.9% | |
| Operating Income | 263.16M | 424.87M | 61.4% | |
| Net Income | 113.10M | 216.93M | 91.8% | |
| EPS | 0.23 | 0.43 | 87.0% | |
| EBITDA | 241.49M | 366.89M | 51.9% | |
| Gross Margin | 49.59% | 27.19% | 45.2% | |
| Operating Margin | 15.51% | 19.05% | 22.8% | |
| Net Income Margin | 6.67% | 9.73% | 45.9% | |
| R&D Expenses | 1.52M | 0 | 100.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.23B | 1.70B | 1.44B | — | — |
| Gross Profit | 606.41M | 841.42M | 666.28M | — | — |
| Operating Income | 424.87M | 263.16M | 74.98M | — | — |
| Net Income | 216.93M | 113.10M | -10.55M | — | — |
| EPS | 0.43 | 0.23 | -0.02 | — | — |
| EBITDA | 366.89M | 241.49M | 101.69M | — | — |
| Gross Margin | 27.19% | 49.59% | 46.39% | — | — |
| Operating Margin | 19.05% | 15.51% | 5.22% | — | — |
| Net Income Margin | 9.73% | 6.67% | -0.73% | — | — |
| R&D Expenses | 0 | 1.52M | 3.61M | — | — |
Financial Metrics
Want to dive deeper into SGHC's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics